GENEVA, March 23 -- SANOFI (46 avenue de la Grande Armee75017 Paris) filed a patent application (PCT/EP2025/075752) for "CRYSTALLINE FORM OF A PYRIDAZINE NLRP3 INHIBITOR" on Sep 10, 2025. With publication no. WO/2026/057634, the details related to the patent application was published on Mar 19, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MARGUET, Frank (c/o Sanofi, Patent Department46 avenue de la Grande Armee75017 Paris), RONAN, Baptiste (c/o Sanofi, Patent Department46 avenue de la Grande Armee75017 Paris)
Abstract: The present disclosure relates to a compound of formula (I) which is ...